Transcode Therapeutics, Inc. Common Stock Shares Outstanding

Quick Answer

Transcode Therapeutics, Inc. reported Common Stock Shares Outstanding of 1.03 million shares for the year ending 2024.

  • Transcode Therapeutics, Inc. showed an increase of +5,312.3% in Common Stock Shares Outstanding from 2023 to 2024.
  • This data is from Transcode Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on April 15, 2025.
  • XBRL data for this metric is available from 2020 to 2024 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 5 years of available data (2020 to 2024), Transcode Therapeutics, Inc.'s Common Stock Shares Outstanding has declined by 77.8%.
  • Historical annual values: Fiscal year 2024: 1.03 million shares | Fiscal year 2023: 19,014 shares | Fiscal year 2022: 16,222 shares | Fiscal year 2021: 12.90 million shares | Fiscal year 2020: 4.64 million shares.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: